A detailed history of Nisa Investment Advisors, LLC transactions in Vericel Corp stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 2,523 shares of VCEL stock, worth $143,028. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,523
Previous 2,484 1.57%
Holding current value
$143,028
Previous $113,000 6.19%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$42.25 - $53.56 $1,647 - $2,088
39 Added 1.57%
2,523 $106,000
Q2 2024

Jul 19, 2024

BUY
$41.71 - $52.9 $9,176 - $11,638
220 Added 9.72%
2,484 $113,000
Q1 2024

May 01, 2024

BUY
$32.52 - $52.33 $1,333 - $2,145
41 Added 1.84%
2,264 $117,000
Q2 2023

Aug 11, 2023

BUY
$29.0 - $38.37 $5,220 - $6,906
180 Added 8.81%
2,223 $83,000
Q4 2022

Feb 02, 2023

SELL
$17.65 - $27.37 $317 - $492
-18 Reduced 0.87%
2,043 $54,000
Q3 2022

Nov 07, 2022

BUY
$22.62 - $32.54 $859 - $1,236
38 Added 1.88%
2,061 $55,000
Q2 2022

Aug 03, 2022

SELL
$22.88 - $39.45 $67,427 - $116,259
-2,947 Reduced 59.3%
2,023 $51,000
Q1 2022

Apr 29, 2022

SELL
$31.69 - $43.29 $18,855 - $25,757
-595 Reduced 10.69%
4,970 $190,000
Q4 2021

Feb 03, 2022

BUY
$35.2 - $52.6 $104,544 - $156,222
2,970 Added 114.45%
5,565 $198,000
Q4 2020

Jan 25, 2021

BUY
$18.53 - $31.5 $36,133 - $61,425
1,950 Added 302.33%
2,595 $80,000
Q2 2020

Jul 27, 2020

BUY
$8.5 - $15.82 $552 - $1,028
65 Added 11.21%
645 $9,000
Q3 2019

Oct 17, 2019

BUY
$14.93 - $19.83 $4,031 - $5,354
270 Added 87.1%
580 $9,000
Q3 2018

Oct 16, 2018

BUY
$9.1 - $14.8 $2,821 - $4,588
310 New
310 $4,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.